News
11h
Live Science on MSNExperimental HIV vaccines show promise in early safety test
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...
Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...
People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...
14h
News-Medical.Net on MSNSingle injection of gene therapy at birth may offer lasting protection against HIV
A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...
AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...
The Trump administration has eliminated some grants aimed at HIV education and prevention and cut funding at the Centers for ...
15h
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIV
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
To find out what may be behind these numbers, Dr. Ann Khalsa, a clinician at the Valleywise Health McDowell Clinic spoke with ...
GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results